You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,916,923


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,916,923
Title: Venlafaxine for the treatment of generalized anxiety disorder
Abstract:This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia iervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: ##STR1## in which A is a moiety of the formula ##STR2## where the dotted line represents optional unsaturation; R.sub.1 is hydrogen or alkyl; R.sub.2 is alkyl; R.sub.4 is hydrogen, alkyl, formyl, or alkanol; R.sub.5 and R.sub.6 are, independently, hydrogen, hydroxyl, aakyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R.sub.7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.
Inventor(s): Rudolph; Richard L. (Berwyn, PA), Upton; G. Virginia (Radnor, PA)
Assignee: American Home Products Corporation (Madison, NJ)
Application Number:08/835,780
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,916,923

Introduction

Patent 5,916,923, like any other patent, is a complex document that outlines the invention, its claims, and the legal protections afforded to the inventor. To delve into the specifics of this patent, it is crucial to understand the components that make up a patent, the process of patenting, and the legal framework surrounding it.

What is a Patent?

A patent is a form of intellectual property that gives the inventor exclusive rights to make, use, and sell the invention for a specified period, usually 20 years from the date of filing. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents[2].

The Patent 5,916,923

Background

To analyze the scope and claims of Patent 5,916,923, one must first understand the background of the invention. This involves reading the patent's abstract, description, and background sections. These sections provide context on what the invention is, its purpose, and how it differs from existing technologies.

Claims

The claims section of a patent is the most critical part, as it defines the scope of the invention and what is legally protected. Claims are statements that define the invention and distinguish it from prior art. They are typically divided into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

For example, if a patent has an independent claim that describes a new type of engine, a dependent claim might describe a specific component of that engine.

Patent Claims Analysis

Claim Structure

The structure of the claims in Patent 5,916,923 would follow the standard format:

  • Claim 1: An independent claim that broadly defines the invention.
  • Claim 2-10: Dependent claims that narrow down the invention by adding specific features or limitations.

Claim Scope

The scope of the claims determines what is protected by the patent. A broader claim scope provides wider protection but is more likely to be challenged for validity. Narrower claims are more specific and less likely to be challenged but offer less protection.

Patent Landscape

Prior Art

Understanding the prior art is essential to assessing the novelty and non-obviousness of the invention. Prior art includes all existing knowledge and inventions in the field that predate the filing of the patent. The USPTO conducts a thorough search of prior art during the patent examination process[4].

Related Patents

The patent landscape includes other patents related to the same field or technology. Tools like the Global Dossier provided by the USPTO can help identify related applications and patents filed in other jurisdictions[4].

Legal Framework

Patent Certification and Exclusivity

In the context of pharmaceutical patents, such as those related to Patent 5,916,923, the legal framework involves patent certification and exclusivity periods. For example, under the Hatch-Waxman Act, generic drug manufacturers must submit a patent certification or statement regarding the patents listed in the Orange Book for the reference listed drug (RLD)[1].

Case Law and Precedents

Judicial Interpretations

Court cases and judicial interpretations can significantly impact the scope and claims of a patent. For instance, cases like Hadfield et al. v. Jerussi et al. can provide insights into how courts interpret patent claims and determine their validity[5].

Statistical Analysis

Patent Claims Research Dataset

The USPTO provides datasets, such as the Patent Claims Research Dataset, which can be used to analyze trends and statistics related to patent claims. This dataset includes detailed information on claims from U.S. patents granted between 1976 and 2014 and can help in understanding the scope and complexity of patent claims[3].

Practical Implications

Enforcement and Litigation

The scope and claims of a patent are crucial in enforcement and litigation. A well-crafted set of claims can help in defending the patent against infringement and challenges. Conversely, poorly drafted claims can lead to invalidation or narrowing of the patent's scope.

Licensing and Collaboration

The clarity and breadth of patent claims also affect licensing agreements and collaborations. Clear and broad claims can make the patent more attractive for licensing, while narrow or ambiguous claims might deter potential partners.

Key Takeaways

  • Claims Definition: The claims section of a patent is critical and defines the legal scope of the invention.
  • Prior Art: Understanding prior art is essential for assessing the novelty and non-obviousness of the invention.
  • Legal Framework: Patent certification and exclusivity periods are important in pharmaceutical patents.
  • Judicial Interpretations: Court cases can significantly impact the interpretation and validity of patent claims.
  • Statistical Analysis: Datasets like the Patent Claims Research Dataset can provide valuable insights into patent claim trends.

FAQs

  1. What is the purpose of the claims section in a patent?

    • The claims section defines the scope of the invention and what is legally protected.
  2. How does the USPTO determine the validity of patent claims?

    • The USPTO conducts a thorough search of prior art and examines the claims for novelty, non-obviousness, and utility.
  3. What is the significance of the Orange Book in pharmaceutical patents?

    • The Orange Book lists patents that claim the drug or a method of using the drug, and generic manufacturers must submit patent certifications or statements regarding these patents.
  4. How can the Global Dossier help in patent research?

    • The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping users identify related patents and applications.
  5. Why is statistical analysis of patent claims important?

    • Statistical analysis can provide insights into trends and complexities of patent claims, helping inventors and patent attorneys craft stronger patents.

Sources

  1. FDA Response to Citizen Petition: Regulations.gov
  2. U.S. Patent and Trademark Office (USPTO): USA.gov
  3. Patent Claims Research Dataset: USPTO
  4. Search for Patents: USPTO
  5. Hadfield et al. V. Jerussi et al.: Casetext

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,916,923

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,916,923

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 213407 ⤷  Subscribe
Austria 342715 ⤷  Subscribe
Austria 392893 ⤷  Subscribe
Australia 5831298 ⤷  Subscribe
Australia 6592994 ⤷  Subscribe
Canada 2126305 ⤷  Subscribe
Cyprus 2315 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.